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There have been two recent trends in living kidney
donation: increased acceptance of living donors and
increased acceptance of laparoscopic nephrectomy
(LN).
We surveyed 234 UNOS-listed kidney transplant pro-
grams to determine current living donor morbidity
and mortality for open nephrectomy, hand-assisted
LN, and non-hand-assisted LN.
Of the 234 centers, 171 (73%) responded. Between
1/1/1999 and 7/1/2001, these centers carried out
10 828 living donor nephrectomies: 52.3% open,
20.7% hand-assisted LN, and 27% non-hand-assisted
LN. Two donors (0.02%) died from surgical complica-
tions and one is in a persistent vegetative state (all
after LN). Reoperation was necessary in 22 (0.4%)
open, 23 (1.0%) hand-assisted LN, and 21 (0.9%) non-
hand-assisted LN cases (p = 0.001). Complications not
requiring reoperation were reported for 19 (0.3%)
open, 22 (1.0%) hand-assisted LN, and 24 (0.8%) non-
hand-assisted LN cases (p = 0.02). Readmission rate
was higher for LN (1.6%) vs. open (0.6%) donors
(p < 0.001), almost entirely as a result of an increase
in gastrointestinal complications in LN donors.
Morbidity and mortality for living donor nephrectomy
at transplant centers in the United States remain low.
We provide current data from which comprehensive
informed consent can be obtained from donors.
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Introduction
Two major recent developments have led to the increased
acceptance of living kidney donation. First, kidney trans-
plant results have improved, so more patients with
end-stage renal disease (ESRD) have opted for a trans-
plant rather than dialysis. At the same time, the number of
cadaver kidneys available has not increased. Thus, the
waiting time for a cadaver kidney transplant has progres-
sively increased, and, for the first time, a significant
portion of patients on the waiting list are dying before
receiving a cadaver kidney (1). In the last few years, as a
partial solution to the cadaver kidney shortage, the
number of living kidney donors has markedly increased (2).
Second, the introduction of laparoscopic nephrectomy (LN)
has been associated with less pain and a quicker recovery
time than conventional open nephrectomy (3,4). As a result,
more potential living donors may volunteer (5).
The major disadvantage of a living donor transplant is the
risk to the donor, including perioperative morbidity and
mortality, plus the long-term risk of living with a single
kidney. Morbidity and mortality after open nephrectomy
were described a decade ago (6,7).
Nonetheless, we were concerned that (a) the pressure to
increase acceptance of living donors may have led to
relaxation of acceptance criteria and a resultant change
in donor outcomes and (b) the morbidity and mortality
rates with LN may differ from those of open nephrectomy.
Thus, to address current donor morbidity and mortality
rates, we conducted a survey of transplant centers in the
United States.
Methods
A survey was sent to all transplant centers listed with the United Network
for Organ Sharing (UNOS).
The Human Subjects Committee at the University of Minnesota deter-
mined that the survey was exempt from review under federal guidelines
[45 CFR Part 46–101 (b) Category #4]. The research project was also
reviewed by the Investigational Review Board of the University of
Maryland School of Medicine, which also found it exempt from formal review
(exemption number STB-070201). We asked centers to provide the total
number of donors they accepted between January 1, 1999, and July 1,
2001, and then the total number performed using each surgical technique:
open nephrectomy, hand-assisted (HA) LN, and non-HA LN. For each of
these three techniques, we asked for information on mortality, reoperation,
complications, and readmissions. For donors having problems (reoperation,
complications, readmissions) after either type of LN, we asked whether the
problems occurred early or late in the center’s experience (<25 cases, 25–50
cases, or>50 cases). Finally, we asked whether centers were aware of
donors being denied health insurance or life insurance as a consequence of
uninephrectomy.




The incidence of reoperation, complications, and readmissions was
compared among the three procedures using chi-square and/or Fisher’s
exact tests.
Results
Of 234 kidney transplant centers surveyed, 171 (73%)
responded. Between January 1, 1999, and July 1, 2001,
these centers carried out 10 828 living donor (LD) nephrec-
tomies. This represents 85% of living donor transplants
reported to the UNOS in this interval. Of these, 5660
(52.3%) were carried out by open nephrectomy, 2239
(20.7%) by HA LN, and 2929 (27%) by non-HA LN.
Of the 10 828 donors, two (0.02%) died from surgical
complications (one from pulmonary embolus on post-
operative day 5 after HA LN; one unspecified, also after
LN). A third donor is in a persistent vegetative state after
an intraoperative bleed and hypotension during non-HA
LN (carried out within the first 25 cases of the center’s
experience). Including all three of these donors, the
calculated overall mortality rate has been 0.03%. In addi-
tion, two other donors have died from nonoperative
causes (one murder and one suicide, each at 6 months
after donation).
Reoperation has been performed in 25 (0.4%) open, 23
(1.0%) HA LN, and 21 (0.9%) non-HA LN donors
(p = 0.001). Reasons for reoperation differed by donation
technique (Table 1). Bleeding was a more common reason
for reoperation with non-HA LN donors (p = 0.02); hernia
with HA LN and open donors (p = 0.001). For LN donors,
the four main reasons for reoperation seemed to have
little relation to the center’s LN experience, although the
numbers in each group are small (Table 2).
Postoperative complications not requiring reoperation
were reported for 19 (0.3%) open, 22 (1.0%) HA LN, and
24 (0.8%) non-HA LN donors (p = 0.02) (Table 3). These
numbers are likely underestimated. For example, some
centers may not have reported bleeding requiring trans-
fusions unless reoperation resulted.
One unusual complication (rhabdomyolysis) (n = 6.0.1%)
seemed to be related to large donors and a prolonged
operative time. The occurrence of bleeding (not requiring
reoperation) and of rhabdomyolysis seemed to have no
relation to the center’s LN experience (Table 4).
Reasons for readmissions are shown, by donation techni-
que, in Table 5. Our survey separated readmissions by
open nephrectomy vs. LN, but did not separate HA LN
from non-HA LN. The readmission rate was significantly
increased for LN donors (p< 0.001), almost entirely as a
result of gastrointestinal complications (nausea and vomit-
ing, dehydration, ileus, or constipation). It is unclear how
much of this increase was the result of the intraperitoneal
approach or how much was because of the goal of early
hospital discharge after LN. For 45 readmissions after LN,
we were able to determine the donation technique: we
found no difference in reasons for readmissions for HA LN
vs. non-HA LN donors (Table 6).
Finally, five centers reported that one or more donors have
had difficulty obtaining health insurance or life insurance.
For three of these centers, the issue was quickly resolved
after direct communication between the center and the
insurance company. One donor who was denied personal
insurance was eventually covered by a spouse’s policy.
Discussion
The most challenging dilemma in kidney transplantation
today is an insufficient number of suitable organs for
transplantation and the resultant increased waiting time
for prospective cadaver donor recipients. In the last dec-
ade, the number of patients on the waiting list for a kidney
in the United States has increased from 19 046 to 47 831
(2) and the median time from listing to transplant has
increased from 514 to more than 1131 days. One potential
solution to this problem is to increase the number of LD
transplants. In 2001, the number of LD donors exceeded
the number of cadaver donors.
In addition to the longer waiting times for a cadaver kid-
ney, other possible reasons for this recent LD increase
include the following: First, patient and graft survival rates
after LD transplants are better than after cadaver trans-
plants (8). Outcome after preemptive transplants (which
are much more likely with LD) is better than outcome for
patients on dialysis pretransplant (9,10). Clearly, from
a recipient perspective, an LD transplant is better. Second,
numerous studies have shown that outcome after living
Table 1: Reasons for reoperation; by donation technique
Open (n = 5660) HA LN (n = 2239) Non-HA LN (n = 2929)
Bleeding* 9 (0.15%) 4 (0.18%) 13 (0.45%)
Bowel obstruction** 3 (0.05%) 6 (0.27%) 3 (0.1%)
Bowel injury – 2 (0.1%) 4 (0.14%)
Hernia*** 10 (0.18%) 11 (0.5%) 1 (0.03%)
*p = 0.02; **p = 0.03; ***p = 0.001.
HA = hand-assisted; LN = laparoscopic nephrectomy.
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Table 2: Reasons for reoperation by experience and LN technique
Center’s LN experience (n) HA LN (n) Non-HA LN (n)
Bleeding >50 1 5
25 2 5
<25–50 1 2
Bowel obstruction >50 2 –
<25 1 3
25–50 3 –
Bowel injury >50 – 2
<25 2 –
25–50 – 2
Hernia >50 1 –
<25 3 –
25–50 5 1
HA = hand-assisted; LN = laparoscopic nephrectomy.
Table 3: Postoperative complications not requiring reoperation, by donation technique
Open (n = 5660) HA LN (n = 2239) Non-HA LN (n = 2929)
Bleeding* 4 (0.1%) 10 (0.45%) 6 (0.2%)
Rhabdomyolysis** – 2 (0.09%) 4 (0.13%)
Deep vein thrombosis/pulmonary embolus 1 (0.02%) 2 (0.09%) 3 (0.1%)
Prolonged ileus – 1 (0.05%) 2 (0.06%)
Pneumothorax 4 (0.09%) 1 (0.05%) –
Other 10 (0.18%) 6 (0.27%) 9 (0.3%)
Total*** 19 (00.3%) 22 (1%) 24 (00.8%)
*p = 0.03; **p = 0.001; ***p = 0.02.
HA = hand-assisted; LN = laparoscopic nephrectomy.
Table 4: Complications by experience and LN technique
Center’s LN experience (n) HA LN (n) Non-HA LN (n)
Bleeding > 50 4 2
< 25 1 –
25–50 4 4
Rhabdomyolysis > 50 – –
< 25 2 –
25–50 – 3
HA = hand-assisted; LN = laparoscopic nephrectomy.
Table 5: Reasons for readmissions, by donation technique
Open (n = 5660) All LN (n = 5168) p
Nausea and vomiting, dehydration, ileus 5 28 0.001
Constipation – 7 0.006
Diarrhea – 1 NS
Wound (infection/dehiscence) 7 4 NS
Reoperation
Small bowel obstruction 2 3 NS
Hernia 10 6
Other 12 18 NS
Total 36 (0.6%) 67 (1.3%) 0.001
LN = laparoscopic nephrectomy; NS = not statistically significant.
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unrelated donor transplants is similar to outcome after
non-HLA-identical living related donor transplants (11,12).
Acceptance of unrelated donors significantly increases the
potential donor pool. Third, LN is now an attractive option,
so more recipients appear to be more receptive to accept-
ing an LD kidney (5).
The major disadvantage of LD transplants is the risk to the
donor: both the operative risk and the long-term risk of
living with one kidney. The operative risk has previously
been described for open nephrectomy. Perioperative
mortality is 0.03% (6,7); complications, mostly minor,
occur in < 10% of donors (13). To date, follow-up studies
have not shown increased long-term risk after open
nephrectomy (6,14), but it is recognized that some donors
have eventually developed renal failure (15).
Our current survey also suggests that, with the introduc-
tion of LN, perioperative mortality is unchanged from a
decade ago. Of 10 828 donors between January 1, 1999,
and July 1, 2001, two have died and one is in a persistent
vegetative state (a total of 0.03%). A concern is that all
three of these donors had undergone LN. Certainly, the
intraoperative bleed and the ‘unspecified’ case may have
been related to the surgical technique. But the third
problem, fatal pulmonary embolus, has been reported
after open nephrectomy; in fact, it was the most common
cause of death in a previous survey (6).
To date, reoperation was carried out in < 1% of all donor
nephrectomy cases. Although we noted a statistically sig-
nificant difference in reoperation rates between the two
techniques, the difference was small. Reasons for reop-
eration did differ. Bleeding was a more common etiology
with non-HA LN donors; bowel obstruction, with HA LN
donors; and hernia, with HA LN and open nephrectomy
donors. It is unknown whether additional LN experience
will result in lower reoperation rates. Our data would
suggest that complications occurred in centers with both
a large and small experience. In addition, in centers with
a large experience, complications occurred late as well as
early. However, we did not differentiate between a cen-
ter’s experience and an individual surgeon’s experience. It
may be that some complications occurring late in centers
with a large experience actually were early in an individual
surgeon’s experience. One difference that will persist is
that LN is an intraperitoneal operation whereas open
nephrectomy is a retroperitoneal operation (although retro-
peritoneal LN has been described [16]). Thus, the risk of
requiring reoperation for bowel obstruction, although
small, will likely be higher with LN than with open
nephrectomy. This possibility should be discussed with
potential donors.
We noted significantly more readmissions after LN
(vs. open nephrectomy). Rather than reflecting an
increased complication rate, this difference may reflect
attempts to shorten the hospital stay for LN donors.
Numerous studies have demonstrated that LN donors
require less pain medication and have a shorter hospital
stay than open nephrectomy donors (4,17). It may be that
a slightly increased readmission rate for a small number of
donors will ultimately be an acceptable outcome in
exchange for a shorter hospital stay for the majority.
Future studies could resolve this question by looking at
total hospitalization time.
Only five responding centers (3%) reported 1 donor
having trouble obtaining health insurance or life insurance.
For three centers, this problem was easily resolved. In all,
only two donors were actually denied insurance: one of
them was eventually covered under a spouse’s policy.
Spital et al. previously reported on the willingness of
almost all insurance companies to provide health insur-
ance or life insurance to donors, without increased rates
(18). Our survey supports their findings.
We recognize that our study has the inherent weakness
associated with a retrospective survey. First, only 73% of
centers (representing 85% of transplants) responded. It is
possible that centers with more complications were less
likely to respond to the survey, and thus we may have
underestimated the complication rate. Second, we asked
open-ended questions about reoperation, complications,
and readmissions. Whereas ‘reoperation’ and ‘readmis-
sions’ are relatively specific, ‘complications’ may have
been interpreted differently by different centers. Third,
we did not ask about laterality of the kidneys removed.
We believe that a well-designed prospective study will be
able to address these issues. We support the establish-
ment of an LD registry to track both short- and long-term
consequences (e.g. death, need for a transplant, renal
function, readmissions, complications) of donor nephrec-
tomy (19).
Table 6: Readmissions after LN, by technique
HA LN (n) Non-HA LN (n) Unspecified (n)
Nausea and vomiting, dehydration, ileus 13 11 3
Constipation 2 3 2
Diarrhea – 1 –
Wound 1 3
Small bowel obstruction 1 3
Hernia 5 –
HA = hand-assisted.
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In summary, morbidity and mortality after donor nephrec-
tomy remain low. Our survey found some differences
between donation techniques in the rates of reoperation,
complications, and readmissions — all higher with LN. But
for each technique, each of these three rates was  1.3%.
Importantly, unlike other surgical patients, organ donors
undergo an operation without any anticipation of physical
benefit. It is essential that the risks be clearly explained to
potential donors. Our survey provides current data from
which comprehensive informed consent can be obtained
from donors.
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